Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
03/16/2000 | CA2341782A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
03/16/2000 | CA2341777A1 Neutral amino acid transporter and gene thereof |
03/16/2000 | CA2341753A1 Bifunctional antibodies and their use in targeting anti-tumour agents |
03/16/2000 | CA2341498A1 Temperature dependent protein purification |
03/16/2000 | CA2341349A1 Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof |
03/16/2000 | CA2341327A1 Novel protein and dna thereof |
03/16/2000 | CA2341307A1 Antibody for detecting possibility of onset of bovine leukemia |
03/16/2000 | CA2341302A1 Lim domain protein homolog |
03/16/2000 | CA2341154A1 Novel receptor protein and method for the diagnosis of an inflammatory disease by using the same |
03/16/2000 | CA2340686A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |
03/16/2000 | CA2340433A1 Tau as a marker for early cns damage |
03/16/2000 | CA2309212A1 Essential bacterial genes and their use |
03/15/2000 | EP0985039A2 Artificial antibody polypeptides |
03/15/2000 | EP0985038A1 Sodium channel receptor |
03/15/2000 | EP0985036A1 Zinc ring protein |
03/15/2000 | EP0985033A2 Polyvalent and polyclonal libraries |
03/15/2000 | EP0985032A1 RIBOSOME COMPLEXES AS SELECTION PARTICLES FOR $i(IN VITRO) DISPLAY AND EVOLUTION OF PROTEINS |
03/15/2000 | EP0985030A2 New human ribonuclease |
03/15/2000 | EP0984987A2 A soluble laminin receptor precursor and methods to ihnibit its interactions |
03/15/2000 | EP0984983A2 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and a kinase domain |
03/15/2000 | EP0842434B1 Method for the quantitative measurement of human acute phase serum amyloid a protein; recombinant protein; specific antibody |
03/15/2000 | EP0658205B1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy |
03/15/2000 | EP0648279B1 Acceptor for fucosyltransferase |
03/15/2000 | EP0610286B1 Recombinant immunotoxins |
03/15/2000 | EP0551325B1 Method of testing for salmonella |
03/15/2000 | CN1247568A Fibroblast growth factor homologs |
03/15/2000 | CN1247567A Tumor necrosis factor receptor alfa 6 and receptor beta 6 |
03/15/2000 | CN1247566A Novel peptide, novel DNA, and novel antibody |
03/15/2000 | CN1247472A Treatment of lupus nephritis with anti-CD40L compounds |
03/15/2000 | CN1247229A Paddy rice group of preventing rice blast |
03/14/2000 | US6037462 Nucleic acids sequences with somatic adjustments in the multiple tumor suppressor gene in human cancers; for diagnosis and treatment of human cancer; anticarciongenic agents; antitumor agents |
03/14/2000 | US6037461 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
03/14/2000 | US6037456 Process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
03/14/2000 | US6037455 Propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
03/14/2000 | US6037454 Humanized anti-CD11a antibodies |
03/14/2000 | US6037453 Immunoglobulin variants |
03/14/2000 | US6037450 Genetically engineered binding polypeptide where carboxy terminal cysteine is replaced or is not palmitoylated; for the diagnosis and treatment of inflammation and autoimmune diseases; antiinflammatory agents |
03/14/2000 | US6037449 Polypeptide associated with bone and dentin tissues; for osteoporosis and bone cancer diagnosis; antiinflammatory agents |
03/14/2000 | US6037448 Chimeric viral protein with human lymphocyte determinant; for vaccine development against infection |
03/14/2000 | US6037320 Neurotrophic factor (NT-4) |
03/14/2000 | US6037159 Polynucleotide coding a protein with the enzymatic activity to transfer sulfate groups to an oligosaccharide |
03/14/2000 | US6037149 Nucleotide sequence coding human interleukin-9; for the diagnosis of sensitivity to allergy and asthma |
03/14/2000 | US6037119 Screening for modulators of enzyme activity; propagating cells transformed or transfected with nucleotide sequences coding guanosine monophosphate, preparing extracts, screening for modulators |
03/14/2000 | US6036956 Method and dosage form using an antagonist to gamma interferon to control MHC-associated autoimmune disease |
03/14/2000 | US6036955 Antitumor agents |
03/14/2000 | US6036954 Polypeptides with sequence |
03/14/2000 | CA2281935A1 Streptomyces avermitilis regulatory genes for increased avermectin production |
03/14/2000 | CA2143335C Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
03/14/2000 | CA2123593C Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
03/14/2000 | CA2071205C Cell surface antigen associated with cellular apoptosis |
03/14/2000 | CA2008817C M-csf monoclonal antibodies that recognize a neutralizing conformational epitope |
03/14/2000 | CA1340927C Method for increasing the sensitivity of assays for target ligand |
03/09/2000 | WO2000012762A1 A novel protein related to melanoma-inhibiting protein and uses thereof |
03/09/2000 | WO2000012758A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
03/09/2000 | WO2000012737A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
03/09/2000 | WO2000012723A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
03/09/2000 | WO2000012722A1 A novel human lysozyme gene, its encoding polypeptide and the method preparing for them |
03/09/2000 | WO2000012721A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
03/09/2000 | WO2000012717A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |
03/09/2000 | WO2000012710A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
03/09/2000 | WO2000012709A2 Phelix: a testis-specific protein expressed in cancer |
03/09/2000 | WO2000012706A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
03/09/2000 | WO2000012703A2 Protein transport-associated molecules |
03/09/2000 | WO2000012702A2 Human genes differentially expressed in colorectal cancer |
03/09/2000 | WO2000012694A1 Chromosome 1-linked prostate cancer susceptibility gene and multisite tumor suppressor |
03/09/2000 | WO2000012689A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
03/09/2000 | WO2000012688A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene |
03/09/2000 | WO2000012685A2 Genes associated with neurotransmitter processing |
03/09/2000 | WO2000012679A1 Novel ubiquitin ligases as therapeutic targets |
03/09/2000 | WO2000012678A2 Staphylococcus aureus genes and polypeptides |
03/09/2000 | WO2000012562A1 HUMAN ANTI-FACTOR IX/IXa ANTIBODIES |
03/09/2000 | WO2000012561A1 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same |
03/09/2000 | WO2000012560A1 Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody |
03/09/2000 | WO2000012559A1 Monoclonal antibodies against s100 |
03/09/2000 | WO2000012558A1 Human monoclonal antibodies directed against the islet cell antigen ia-2 |
03/09/2000 | WO2000012557A1 Discrimination of glutenin subunits of wheat |
03/09/2000 | WO2000012556A1 High-affinity antibodies |
03/09/2000 | WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3 |
03/09/2000 | WO2000012549A1 Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same |
03/09/2000 | WO2000012545A2 Antibodies specific for bladder nuclear matrix proteins blca-1 to blca-6 |
03/09/2000 | WO2000012544A2 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor |
03/09/2000 | WO2000012535A2 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
03/09/2000 | WO2000012532A1 Factor 8 homologue nucleic acids, polypeptides, methods, uses |
03/09/2000 | WO2000012531A1 Ratc |
03/09/2000 | WO2000012529A1 Sperm antigens associated with infertility |
03/09/2000 | WO2000012133A1 Neisseria spp. polypeptide, nucleic acid sequence and uses thereof |
03/09/2000 | WO2000012132A1 Staphylococcal immunotherapeutics via donor selection and donor stimulation |
03/09/2000 | WO2000012131A1 Multicomponent vaccines |
03/09/2000 | WO2000012130A1 Rp105 agonists and antagonists |
03/09/2000 | WO2000012126A1 Autoantibody inhibitors |
03/09/2000 | WO2000012113A2 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions |
03/09/2000 | WO2000012106A1 Gabab1aa receptor |
03/09/2000 | WO2000012105A1 RAMP2a: RECEPTOR ACTIVITY MODIFYING PROTEIN-2a |
03/09/2000 | WO2000012103A1 Method for removal of hiv and other viruses from blood |
03/09/2000 | WO2000012066A1 Alginate capsules for use in the treatment of brain tumour |
03/09/2000 | WO2000000607B1 A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid |
03/09/2000 | WO1999066327A3 Cartilage resorption assays |
03/09/2000 | WO1999062548A9 Methods and compositions for diagnosing tauopathies |
03/09/2000 | WO1999062537A9 Methods and agents for modulating the immune response and inflammation involving monocyte and dendritic cell membrane proteins |
03/09/2000 | WO1999061477A3 Monoclonal antibody and assay for detecting piiinp |